Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Wiemi Douoguih

Sports Medicine Washington, DC Medical Doctor

NPI 1669565495 CMS profile 302204

106 Irving St Nw, Suite 215, Washington, DC 20010

Open in the dashboard

General payments

$102,006

199 records reported · program years 2019–2025

Research payments

$13,906

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$222,502 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Wiemi Douoguih of Washington, DC is reported in the CMS Open Payments database as having received $102,006 across 199 general payments and $13,906 in research payments paid to them. Separately, studies naming them as principal investigator received $222,502 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,576 31
2024 General $35,834 29
2024 Research $13,906 1
2023 General $13,338 29
2022 General $8,329 13
2021 General $15,013 36
2020 General $8,672 34
2019 General $12,245 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wiemi Douoguih
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Wiemi Douoguih were reported at $8,576. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Wiemi Douoguih Sports Medicine median Middle half National median
2019 $12,245 $1,176 $199–$4,249 $163
2020 $8,672 $708 $96–$2,890 $114
2021 $15,013 $1,213 $152–$3,994 $132
2022 $8,329 $1,230 $159–$3,998 $149
2023 $13,338 $584 $146–$2,836 $160
2024 $35,834 $628 $163–$3,168 $164
2025 $8,576 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $93,849 163 payments
  2. Newclip USA LLC $4,519 7 payments
  3. Supreme Orthopedic Systems, LLC $2,655 20 payments
  4. Bone Support Inc. $363 3 payments
  5. Stryker Corporation $148 1 payment
  6. Smith+Nephew, Inc. $143 1 payment
  7. KCI USA, Inc $125 1 payment
  8. Canary Medical USA LLC $100 1 payment
  9. Zimmer Biomet Holdings, Inc. $72 1 payment
  10. Biedermann Motech, Inc. $33 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $60,495 16 payments
  2. Travel and Lodging $27,060 62 payments
  3. Consulting Fee $8,907 6 payments
  4. Food and Beverage $4,343 114 payments
  5. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. CERAMENTBONE VOID FILLER $363 3 payments
  2. CERAMENT G $363 3 payments
  3. ACUFEX $143 1 payment
  4. PREVENA $125 1 payment
  5. Juggerknotless Soft Anchor $72 1 payment
  6. KNEE & HIP IMPLANTS SUSPENSORY FIXATION ACL TIGHTROPE $69 3 payments
  7. Arthrex $41 1 payment
  8. Distal Radius Plating System 2.0 $33 1 payment
  9. Proximal Humerus Plating System $33 1 payment
  10. Olecranon Plating System $33 1 payment
  11. Other $28 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arthrex, Inc. $13,906 1 payment

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$42,503

Of which drugs: $1,887

Medicare patients

171

Average age 73

Services billed

851

113 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 31%
Ischemic heart disease 22%
Chronic kidney disease 18%
Cancer 18%
Depression 13%
COPD 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 34 332 $184

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

200 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record